siRNA for ERK5 or MEF2 reduced CD36 mRNA expression in resting primary (Figure 1C) and in transformed (Figure S1D) hepatocytes, and in resting or DCA-treated OCI-AML-3 cells (Figure 1D). Here, MEF2A is linked to acute myeloid leukemia.